FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:1454-1462 October 6, 2005 Number 14 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Arky, R. A. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background The normal fasting plasma glucose level was recently defined as less than 100 mg per deciliter (5.55 mmol per liter). Whether higher fasting plasma glucose levels within this range independently predict type 2 diabetes in young adults is unclear.

Methods We obtained blood measurements, data from physical examinations, and medical and lifestyle information from men in the Israel Defense Forces who were 26 to 45 years of age.

Results A total of 208 incident cases of type 2 diabetes occurred during 74,309 person-years of follow-up (from 1992 through 2004) among 13,163 subjects who had baseline fasting plasma glucose levels of less than 100 mg per deciliter. A multivariate model, adjusted for age, family history of diabetes, body-mass index, physical-activity level, smoking status, and serum triglyceride levels, revealed a progressively increased risk of type 2 diabetes in men with fasting plasma glucose levels of 87 mg per deciliter (4.83 mmol per liter) or more, as compared with those whose levels were in the bottom quintile (less than 81 mg per deciliter [4.5 mmol per liter], P for trend <0.001). In multivariate models, men with serum triglyceride levels of 150 mg per deciliter (1.69 mmol per liter) or more, combined with fasting plasma glucose levels of 91 to 99 mg per deciliter (5.05 to 5.50 mmol per liter), had a hazard ratio of 8.23 (95 percent confidence interval, 3.6 to 19.0) for diabetes, as compared with men with a combined triglyceride level of less than 150 mg per deciliter and fasting glucose levels of less than 86 mg per deciliter (4.77 mmol per liter). The joint effect of a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or more and a fasting plasma glucose level of 91 to 99 mg per deciliter resulted in a hazard ratio of 8.29 (95 percent confidence interval, 3.8 to 17.8), as compared with a body-mass index of less than 25 and a fasting plasma glucose level of less than 86 mg per deciliter.

Conclusions Higher fasting plasma glucose levels within the normoglycemic range constitute an independent risk factor for type 2 diabetes among young men, and such levels may help, along with body-mass index and triglyceride levels, to identify apparently healthy men at increased risk for diabetes.

Source Information

From the Medical Corps Headquarters (A.T., E.I., T.S., I.K.) and the Center for Medical Services (D.T.-M.), Israel Defense Forces Medical Corps; the Department of Internal Medicine A, Sheba Medical Center, Tel-Hashomer (A.T.); the S. Daniel Abraham International Center for Health and Nutrition (I.S., A.R.), the Department of Epidemiology (I.S.), and the Department of Clinical Biochemistry (A.R.), Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva; and the Department of Internal Medicine A, Meir Hospital, Sapir Medical Center, Kfar-Sava (D.P.) — all in Israel.

Drs. Tirosh and Shai contributed equally to the study.

Address reprint requests to Dr. Tirosh at the Department of Internal Medicine A, Sheba Medical Center, Tel-Hashomer, Israel, or at amirt{at}bgumail.bgu.ac.il.

Full Text of this Article

Related Letters:

Normal Fasting Plasma Glucose Levels and Type 2 Diabetes
Gambino R., Reichberg S., Schwartz J. G., Tirosh A., Shai I., Rudich A.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:87-88, Jan 5, 2006. Correspondence

This article has been cited by other articles:

• Abdul-Ghani, M. A., DeFronzo, R. A. (2009). Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes. Diabetes Care 32: S194-S198 [Full Text]  
• Riskin-Mashiah, S., Younes, G., Damti, A., Auslender, R. (2009). First-Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes. Diabetes Care 32: 1639-1643 [Abstract] [Full Text]  
• Zhou, J., Li, H., Ran, X., Yang, W., Li, Q., Peng, Y., Li, Y., Gao, X., Luan, X., Wang, W., Jia, W. (2009). Reference Values for Continuous Glucose Monitoring in Chinese Subjects. Diabetes Care 32: 1188-1193 [Abstract] [Full Text]  
• The International Expert Committee, (2009). International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 32: 1327-1334 [Full Text]  
• Sheehy, A. M., Coursin, D. B., Gabbay, R. A. (2009). Revisiting Screening for Type 2 Diabetes Mellitus: To Screen or Not to Screen, That Is the Question-Reply-I. Mayo Clin Proc. 84: 384-385 [Full Text]  
• Gao, L., Mann, G. E. (2009). Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20 [Abstract] [Full Text]  
• Goth, L. (2008). Catalase Deficiency and Type 2 Diabetes. Diabetes Care 31: e93-e93 [Full Text]  
• Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., Groop, L. (2008). Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes. NEJM 359: 2220-2232 [Abstract] [Full Text]  
• Tirosh, A., Shai, I., Bitzur, R., Kochba, I., Tekes-Manova, D., Israeli, E., Shochat, T., Rudich, A. (2008). Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men. Diabetes Care 31: 2032-2037 [Abstract] [Full Text]  
• Perreault, L., Bergman, B. C., Playdon, M. C., Dalla Man, C., Cobelli, C., Eckel, R. H. (2008). Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?. Am. J. Physiol. Endocrinol. Metab. 295: E428-E435 [Abstract] [Full Text]  
• Genuth, S., Kahn, R. (2008). A Step Backward--or Is it Forward?. Diabetes Care 31: 1093-1096 [Full Text]  
• Gupta, A. K., Dahlof, B., Dobson, J., Sever, P. S., Wedel, H., Poulter, N.R., on behalf of the Anglo-Scandinavian Cardiac Outcom, (2008). Determinants of New-Onset Diabetes Among 19,257 Hypertensive Patients Randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the Relative Influence of Antihypertensive Medication. Diabetes Care 31: 982-988 [Abstract] [Full Text]  
• Korhonen, P., Aarnio, P., Saaresranta, T., Jaatinen, P., Kantola, I. (2008). Glucose Homeostasis in Hypertensive Subjects. Hypertension 51: 945-949 [Abstract] [Full Text]  
• Fleischman, A., Shoelson, S. E., Bernier, R., Goldfine, A. B. (2008). Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults. Diabetes Care 31: 289-294 [Abstract] [Full Text]  
• Tomkin, G. H. (2008). Targets for Intervention in Dyslipidemia in Diabetes. Diabetes Care 31: S241-S248 [Abstract] [Full Text]  
• Pereg, D., Tirosh, A., Shochat, T., Hasdai, D., for the Metabolic, Lifestyle and Nutrition Assessm, (2008). Mild renal dysfunction associated with incident coronary artery disease in young males. Eur Heart J 29: 198-203 [Abstract] [Full Text]  
• Vasan, R. S. (2008). What is an abnormal blood glucose level? Combining lessons from epidemiology and in vivo plaque imaging.. J Am Coll Cardiol Img 1: 46-48 [Full Text]  
• Hadler, N. M. (2008). Oral Hypoglycemics and Diabetic Nephropathy. CJASN 3: 159-162 [Full Text]  
• Oberlinner, C., Neumann, S. M., Ott, M. G., Zober, A. (2008). Screening for pre-diabetes and diabetes in the workplace. Occup Med (Lond) 58: 41-45 [Abstract] [Full Text]  
• Gambino, R. (2007). Glucose: A Simple Molecule That Is Not Simple to Quantify. Clin. Chem. 53: 2040-2041 [Full Text]  
• Tirosh, A., Rudich, A., Shochat, T., Tekes-Manova, D., Israeli, E., Henkin, Y., Kochba, I., Shai, I. (2007). Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men. ANN INTERN MED 147: 377-385 [Abstract] [Full Text]  
• Chiu, C.-J., Milton, R. C, Gensler, G., Taylor, A. (2007). Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 86: 180-188 [Abstract] [Full Text]  
• Bock, G., Dalla Man, C., Campioni, M., Chittilapilly, E., Basu, R., Toffolo, G., Cobelli, C., Rizza, R. (2006). Pathogenesis of Pre-Diabetes: Mechanisms of Fasting and Postprandial Hyperglycemia in People With Impaired Fasting Glucose and/or Impaired Glucose Tolerance. Diabetes 55: 3536-3549 [Abstract] [Full Text]  
• Yamazaki, H., Zawalich, K. C., Zawalich, W. S. (2006). Desensitization of the pancreatic beta-cell: effects of sustained physiological hyperglycemia and potassium. Am. J. Physiol. Endocrinol. Metab. 291: H1381-H1387 [Abstract] [Full Text]  
• Malnick, S.D.H., Knobler, H. (2006). The medical complications of obesity. QJM 99: 565-579 [Full Text]  
• Carpentier, Y. A, Portois, L., Malaisse, W. J (2006). n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 83: S1499-1504S [Abstract] [Full Text]  
• Shaw, J. E., Zimmet, P. Z., Alberti, K. G. M.M. (2006). Point: Impaired Fasting Glucose: The Case for the New American Diabetes Association Criterion. Diabetes Care 29: 1170-1172 [Full Text]  
• Rosenbloom, A. L. (2006). Implications for Primary Care of Diabetes and Impaired Fasting Glucose Prevalence in Adolescents. Arch Pediatr Adolesc Med 160: 550-552 [Full Text]  
• Gambino, R., Reichberg, S., Schwartz, J. G., Tirosh, A., Shai, I., Rudich, A. (2006). Normal Fasting Plasma Glucose Levels and Type 2 Diabetes. NEJM 354: 87-88 [Full Text]  
• (2005). High `Normal' Fasting Glucose Signals Diabetes Risk in Men. DOC News 2: 12-12 [Full Text]  
• (2005). High-Normal Fasting Glucose and Diabetes Risk. Journal Watch Cardiology 2005: 5-5 [Full Text]  
• Tonks, A. (2005). What's new in the other general journals. BMJ 331: 867-868 [Full Text]  
• (2005). High-Normal Fasting Glucose and Diabetes Risk. JWatch General 2005: 1-1 [Full Text]  
• Arky, R. A. (2005). "Doctor, Is My Sugar Normal?". NEJM 353: 1511-1513 [Full Text]